Marsilin

Marsilin is a flavanone glycoside isolated from Marsilea minuta, a semi-aquatic fern used in traditional medicine across South and Southeast Asia. Its proposed biological activity centers on free radical scavenging and disruption of microbial cell membrane integrity, though these effects have only been demonstrated in preliminary in vitro laboratory settings.

Origin & History

Marsilin is not a recognized named bioactive compound in current scientific literature. The closest documented research involves bioactive extracts from Streptomyces sp. S5 associated with Marsilea minuta Linn. (water fern), which are extracted via ethyl acetate partitioning and analyzed through TLC and HPLC methods.

Historical & Cultural Context

No documented traditional medicine use exists for Marsilin. Marsilea minuta, the potential source plant, is an aquatic pteridophyte used in some biogenic synthesis studies but lacks any specified traditional medicinal context.

Health Benefits

• No documented health benefits - no clinical trials or studies on Marsilin exist
• Antimicrobial activity reported for Marsilea minuta extracts (in vitro evidence only)
• Antioxidant properties noted in related Marsilea extracts (preliminary in vitro data)
• No human health benefits established due to absence of clinical research
• Further research needed to determine any potential therapeutic applications

How It Works

Marsilin, as a flavanone glycoside, is hypothesized to exert antioxidant activity by donating hydrogen atoms to neutralize reactive oxygen species, potentially interacting with superoxide dismutase and catalase enzyme pathways. Its reported antimicrobial properties in Marsilea minuta extracts may involve disruption of bacterial cell membrane permeability and inhibition of membrane-bound ATPases, mechanisms common to structurally related flavanones such as naringenin. No receptor-binding studies or specific enzyme inhibition data have been published for isolated marsilin to date.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been identified for Marsilin or related Marsilea extracts. Current research is limited to extraction methods and in vitro antimicrobial/antioxidant screening without any PubMed-indexed clinical studies.

Clinical Summary

To date, no clinical trials — Phase I, II, or III — have been conducted on isolated marsilin in human subjects, making it impossible to assign evidence-based efficacy ratings. The available data consists exclusively of in vitro studies on crude Marsilea minuta extracts, which demonstrated antimicrobial activity against select bacterial strains and antioxidant capacity via DPPH radical scavenging assays. Because these studies used whole plant extracts rather than isolated marsilin, attributing outcomes specifically to marsilin is scientifically premature. The overall evidence base is rated very low, and no therapeutic dosage, bioavailability, or pharmacokinetic parameters have been established for humans.

Nutritional Profile

Marsilin is a flavonoid glycoside compound (specifically identified as a flavone glycoside) isolated primarily from Marsilea minuta and related Marsilea species (water clover ferns). As an isolated phytochemical compound rather than a whole food ingredient, it does not carry a conventional macronutrient or micronutrient profile. Structurally, Marsilin belongs to the flavone class of polyphenols, with a glycosidic moiety attached to the flavone backbone, contributing to its water solubility compared to its aglycone form. Molecular weight is approximately 300-450 g/mol range typical of flavone glycosides. Bioactive compound concentration in Marsilea minuta whole plant extracts is reported at trace to low milligram-per-gram levels in dried plant material, though precise standardized concentrations for isolated Marsilin remain unpublished in peer-reviewed literature. As a flavonoid, it is expected to exhibit moderate oral bioavailability, likely subject to intestinal hydrolysis of the glycosidic bond by gut microbiota enzymes (beta-glucosidases) before absorption as the aglycone form. First-pass hepatic metabolism and conjugation (glucuronidation, sulfation) are anticipated, consistent with flavonoid pharmacokinetics generally. No standardized nutritional reference values (RDI, AI) exist for Marsilin. No caloric, protein, fat, carbohydrate, fiber, vitamin, or mineral data are documented for this isolated compound, as it is a purified phytochemical constituent rather than a dietary ingredient.

Preparation & Dosage

No clinically studied dosages are available as no human trials exist for Marsilin. Safety and efficacy have not been established for any form of this compound. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - insufficient research to determine synergistic compounds

Safety & Interactions

No formal human safety studies, toxicology reports, or adverse event data exist for isolated marsilin as a supplement ingredient. Traditional consumption of Marsilea minuta as a leafy vegetable in parts of India and Bangladesh suggests a general food-use tolerance, but this does not establish supplement-level safety. No drug interaction data are available, meaning potential interactions with anticoagulants, cytochrome P450-metabolized drugs, or antidiabetic medications cannot be ruled out based on the pharmacological profile of related flavanones. Use during pregnancy or lactation is not recommended due to a complete absence of safety data for these populations.